1. Home
  2. CNTX vs VALU Comparison

CNTX vs VALU Comparison

Compare CNTX & VALU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Context Therapeutics Inc.

CNTX

Context Therapeutics Inc.

HOLD

Current Price

$2.16

Market Cap

283.9M

Sector

Health Care

ML Signal

HOLD

Logo Value Line Inc.

VALU

Value Line Inc.

N/A

Current Price

$33.20

Market Cap

311.5M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
CNTX
VALU
Founded
2015
1931
Country
United States
United States
Employees
N/A
117
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
283.9M
311.5M
IPO Year
2021
1995

Fundamental Metrics

Financial Performance
Metric
CNTX
VALU
Price
$2.16
$33.20
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$6.60
N/A
AVG Volume (30 Days)
778.3K
1.2K
Earning Date
05-08-2026
03-16-2026
Dividend Yield
N/A
3.72%
EPS Growth
17.39
8.91
EPS
N/A
1.92
Revenue
N/A
$36,257,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$17.28
Revenue Growth
N/A
1.08
52 Week Low
$0.49
$33.17
52 Week High
$3.62
$40.50

Technical Indicators

Market Signals
Indicator
CNTX
VALU
Relative Strength Index (RSI) 39.13 34.36
Support Level $2.10 N/A
Resistance Level $2.56 $38.26
Average True Range (ATR) 0.14 0.40
MACD -0.01 -0.16
Stochastic Oscillator 14.46 1.49

Price Performance

Historical Comparison
CNTX
VALU

About CNTX Context Therapeutics Inc.

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

About VALU Value Line Inc.

Value Line Inc is a U.S based company. It produces investment periodicals based on underlying research and making available copyright data, including ranking system and other information, to third parties under written agreements for use in third-party managed and marketed investment products and for other purposes. The company markets under brands including Value Line, the Value Line logo, The Value Line Investment Survey, Smart Research, Smarter Investing and a trusted name in Investment Research. Its only operating segment being Publishing.

Share on Social Networks: